Calendrier des promotions Vericel Corporation
Calendrier avancé
Graphique simple
À propos de l'entreprise Vericel Corporation
Vericel Corporation, коммерческая биофармацевтическая компания, исследует, разрабатывает, производит и распространяет клеточные препараты для спортивной медицины и рынков лечения тяжелых ожогов в Соединенных Штатах. Компания продает продукты аутологичной клеточной терапии, включающие MACI, аутологичный клеточный каркас для восстановления симптоматических, а также единичных или множественных дефектов хряща на всю толщину колена; и Epicel, устройство для перманентной замены кожи, используемое в гуманитарных целях для лечения взрослых и детей с глубокими кожными или полнослойными ожогами. plus de détails| IPO date | 1997-02-04 |
|---|---|
| ISIN | US92346J1088 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | https://vcel.com |
| Цена ао | 52.51 |
| Changement de prix par jour: | -0.019% (52.52) |
|---|---|
| Changement de prix par semaine: | -9.12% (57.78) |
| Changement de prix par mois: | -12.07% (59.72) |
| Changement de prix sur 3 mois: | -9.09% (57.76) |
| Changement de prix sur six mois: | +1.67% (51.65) |
| Changement de prix par an: | +9.85% (47.8) |
| Evolution du prix sur 3 ans: | +32.67% (39.58) |
| Evolution du prix sur 5 ans: | +313.79% (12.69) |
| Evolution des prix sur 10 ans: | 0% (52.51) |
| Evolution des prix depuis le début de l'année: | -4.37% (54.91) |
|
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
|||||||||||||||||||||||||||||||||||||
| Date de transaction | Date de divulgation | Insider | Taper | Prix | Volume | Quantité | Partagez jusqu'à, % | Partager après, % | Document |
|---|---|---|---|---|---|---|---|---|---|
| 28.01.2025 | 30.01.2025 | SIEGAL JONATHAN Principal Accounting Officer |
Vente | 61.99 | 242 257 | 3908 | 0 | -0.01 | lien |
| 28.01.2025 | 28.01.2025 | SIEGAL JONATHAN Officer |
Achat | 61.99 | 242 257 | 3908 | 0 | 0.01 | lien |
| 04.12.2024 | 05.12.2024 | Wotton Paul K Director |
Vente | 58.72 | 152 672 | 2600 | 0 | -0.01 | lien |
| 17.10.2024 | 21.10.2024 | Hagen Heidi Director |
Achat | 3.74 | 37 400 | 10000 | 0 | 0.02 | lien |
| 16.10.2024 | 18.10.2024 | GILMAN STEVEN C Director |
Vente | 41.36 | 241 253 | 5833 | 0 | -0.01 | lien |
| 16.10.2024 | 18.10.2024 | GILMAN STEVEN C Director |
Achat | 13.05 | 76 121 | 5833 | 0 | 0.01 | lien |
| 02.10.2024 | 04.10.2024 | GILMAN STEVEN C Director |
Vente | 40.35 | 235 362 | 5833 | 0 | -0.01 | lien |
| 01.10.2024 | 02.10.2024 | SIEGAL JONATHAN Principal Accounting Officer |
Vente | 41.9 | 23 799 | 568 | 0 | 0 | lien |
| 30.09.2024 | 02.10.2024 | SIEGAL JONATHAN Principal Accounting Officer |
Achat | 40.7 | 38 136 | 937 | 0 | 0 | lien |
| 18.09.2024 | 20.09.2024 | GILMAN STEVEN C Director |
Vente | 45.54 | 265 680 | 5834 | 0 | -0.01 | lien |
| 18.09.2024 | 20.09.2024 | GILMAN STEVEN C Director |
Achat | 13.05 | 76 134 | 5834 | 0 | 0.01 | lien |
| 04.09.2024 | 05.09.2024 | GILMAN STEVEN C Director |
Vente | 48.58 | 242 900 | 5000 | 0 | -0.01 | lien |
| 04.09.2024 | 05.09.2024 | GILMAN STEVEN C Director |
Achat | 3.74 | 18 700 | 5000 | 0 | 0.01 | lien |
| 18.07.2024 | 19.07.2024 | Colangelo Dominick President and CEO |
Vente | 51.4 | 899 500 | 17500 | 0 | -0.04 | lien |
| 18.07.2024 | 19.07.2024 | Colangelo Dominick President and CEO |
Achat | 3.02 | 52 850 | 17500 | 0 | 0.04 | lien |
| 17.07.2024 | 19.07.2024 | Colangelo Dominick President and CEO |
Vente | 51.55 | 902 125 | 17500 | 0 | -0.04 | lien |
| 17.07.2024 | 19.07.2024 | Colangelo Dominick President and CEO |
Achat | 3.02 | 52 850 | 17500 | 0 | 0.04 | lien |
| 16.07.2024 | 18.07.2024 | Flynn Sean C. Chief Legal Officer |
Vente | 52.18 | 782 700 | 15000 | 0 | -0.03 | lien |
| 16.07.2024 | 18.07.2024 | Flynn Sean C. Chief Legal Officer |
Achat | 16.25 | 243 750 | 15000 | 0 | 0.03 | lien |
| 12.07.2024 | 16.07.2024 | Mara Joseph Anthony Jr Chief Financial Officer |
Vente | 50 | 250 000 | 5000 | 0 | -0.01 | lien |
| 05.07.2024 | 09.07.2024 | SIEGAL JONATHAN Principal Accounting Officer |
Vente | 45 | 24 525 | 545 | 0 | 0 | lien |
| 20.05.2024 | 21.05.2024 | Hopper Jonathan Mark Chief Medical Officer |
Vente | 49.99 | 499 900 | 10000 | 0 | -0.02 | lien |
| 20.05.2024 | 21.05.2024 | Hopper Jonathan Mark Chief Medical Officer |
Achat | 10.95 | 109 500 | 10000 | 0 | 0.02 | lien |
| 17.05.2024 | 21.05.2024 | Halpin Michael Chief Operating Officer |
Achat | 5.39 | 28 001 | 5195 | 0 | 0.01 | lien |
| 30.04.2024 | 01.05.2024 | Colangelo Dominick President and CEO |
Achat | 11.79 | 299 997 | 25445 | 0 | 0.05 | lien |
| 18.04.2024 | 19.04.2024 | Colangelo Dominick President and CEO |
Vente | 44.59 | 780 325 | 17500 | 0 | -0.04 | lien |
| 18.04.2024 | 19.04.2024 | Colangelo Dominick President and CEO |
Achat | 3.02 | 52 850 | 17500 | 0 | 0.04 | lien |
| 17.04.2024 | 19.04.2024 | Colangelo Dominick President and CEO |
Vente | 46.47 | 813 225 | 17500 | 0 | -0.04 | lien |
| 17.04.2024 | 19.04.2024 | Colangelo Dominick President and CEO |
Achat | 3.02 | 52 850 | 17500 | 0 | 0.04 | lien |
| 09.04.2024 | 11.04.2024 | Rubino Alan L Director |
Achat | 4.12 | 12 360 | 3000 | 0 | 0.01 | lien |
| 27.03.2024 | 29.03.2024 | ZERBE ROBERT L MD Director |
Vente | 51.57 | 169 046 | 3278 | 0 | -0.01 | lien |
| 27.03.2024 | 29.03.2024 | ZERBE ROBERT L MD Director |
Achat | 3.74 | 12 260 | 3278 | 0 | 0.01 | lien |
| 14.03.2024 | 15.03.2024 | Colangelo Dominick President and CEO |
Vente | 44.02 | 770 350 | 17500 | 0 | -0.04 | lien |
| 13.03.2024 | 15.03.2024 | Colangelo Dominick President and CEO |
Vente | 44.67 | 781 725 | 17500 | 0 | -0.04 | lien |
| 13.03.2024 | 15.03.2024 | Colangelo Dominick President and CEO |
Achat | 3.02 | 52 850 | 17500 | 0 | 0.04 | lien |
| 11.03.2024 | 13.03.2024 | Halpin Michael Chief Operating Officer |
Vente | 44.71 | 352 047 | 7874 | 0 | -0.02 | lien |
| 08.03.2024 | 11.03.2024 | Flynn Sean C. SVP, General Counsel |
Vente | 45.33 | 367 853 | 8115 | 0 | -0.02 | lien |
| 07.03.2024 | 11.03.2024 | SIEGAL JONATHAN Principal Accounting Officer |
Vente | 45 | 73 530 | 1634 | 0 | 0 | lien |
| 25.01.2024 | 29.01.2024 | ZERBE ROBERT L MD Director |
Vente | 44.02 | 8 804 | 200 | 0 | 0 | lien |
| 18.01.2024 | 19.01.2024 | Colangelo Dominick President and CEO |
Vente | 38.58 | 645 289 | 16726 | 0 | -0.04 | lien |
| 18.01.2024 | 19.01.2024 | Colangelo Dominick President and CEO |
Achat | 3.02 | 50 513 | 16726 | 0 | 0.04 | lien |
| 17.01.2024 | 19.01.2024 | Colangelo Dominick President and CEO |
Vente | 37.97 | 635 086 | 16726 | 0 | -0.04 | lien |
| 17.01.2024 | 19.01.2024 | Colangelo Dominick President and CEO |
Achat | 3.02 | 50 513 | 16726 | 0 | 0.04 | lien |
| Établissements | Volume | Partager, % |
|---|---|---|
| Blackrock Inc. | 7937063 | 16.41 |
| Brown Capital Management, LLC | 6818933 | 14.09 |
| Vanguard Group Inc | 3374093 | 6.97 |
| RTW Investments LP | 3212794 | 6.64 |
| State Street Corporation | 2664883 | 5.51 |
| Conestoga Capital Advisors, LLC | 2339960 | 4.84 |
| GW&K Investment Management, LLC | 1323306 | 2.74 |
| Morgan Stanley | 1297846 | 2.68 |
| Macquarie Group Limited | 1146193 | 2.37 |
| Loomis Sayles & Company, LP | 1141526 | 2.36 |
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
|---|---|---|---|
| Mr. Dominick C. Colangelo Esq. | CEO, President & Director | 1.54M | 1964 (61 année) |
| Mr. Michael Halpin | Chief Operating Officer | 796.91k | 1962 (63 année) |
| Mr. Joseph Anthony Mara Jr. | CFO & Treasurer | 750.61k | 1976 (49 années) |
| Mr. Eric Burns | Vice President of Finance & Investor Relations | N/A | |
| Mr. Patrick J. Fowler | Senior Vice President of Corporate Development & Strategy | N/A | |
| Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B. | Chief Medical Officer | 672.16k | 1962 (63 année) |
| Mr. Patrick Helfrich | Vice President of Marketing & Commercial Strategy | N/A | |
| Mr. Jonathan D. Siegal | Principal Accounting Officer, VP & Corporate Controller | N/A | |
| Mr. Sean C. Flynn | Chief Legal Officer | 1974 (51 année) | |
| Mr. Mike Gilligan | Senior Vice President of Sales |
Adresse: United States, Cambridge, MA , 64 Sidney Street - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://vcel.com
Site web: https://vcel.com
